Jasserand; Daniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jasserand; Daniel.The latest application filed is for "dual nk2/nk3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation".

Company Profile

0.8.7

Jasserand; Daniel - Weesp NL
Jasserand; Daniel - Hannover DE
Jasserand; Daniel - Lyons FR
Jasserand; Daniel - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors Grant 7,851,630 - Den Hartog , et al. December 14, 2	2010-12-14
1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds Grant 7,767,692 - Jasserand , et al. August 3, 2	2010-08-03
NK1 and NK2-antagonists and compositions and methods of using the same Grant 7,592,344 - Antel , et al. September 22, 2	2009-09-22
Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation App 20070219214 - Jasserand; Daniel ; et al.	2007-09-20
Hydronopol derivatives as agonists on human ORL1 receptors Grant 7,241,770 - Mentzel , et al. July 10, 2	2007-07-10
NK1 and NK2-antagonists and compositions and methods of using the same App 20070149537 - Antel; Jochen ; et al.	2007-06-28
Hydronopol derivatives as agonists on human ORL1 receptors App 20050131004 - Mentzel, Matthias ; et al.	2005-06-16
Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors App 20050075355 - Den Hartog, Jacobus A.J. ; et al.	2005-04-07
1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds App 20040152732 - Jasserand, Daniel ; et al.	2004-08-05
1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them Grant 6,770,649 - Jasserand , et al. August 3, 2	2004-08-03
1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them App 20030125557 - Jasserand, Daniel ; et al.	2003-07-03
N-triazolymethyl-piperazine compounds with neurokinin-receptor antagonist activity App 20020065276 - Jasserand, Daniel ; et al.	2002-05-30
7-fused 2-(piperazinoalkyl) indole derivatives, intermediates and compositions thereof Grant 5,324,725 - Jasserand , et al. June 28, 1	1994-06-28
Antiallergic 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-one compounds Grant 4,672,063 - Jasserand , et al. June 9, 1	1987-06-09
1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same Grant 4,442,102 - Heinemann , et al. April 10, 1	1984-04-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.